Frequency of indicator variables and subsequent outcomes on patient charts: N=237.
| VARIABLE | ABSENT, N (%) | PRESENT, N (%) | MISSING, N (%) |
|---|---|---|---|
| Obesity indicator | 98 (41.35) | 139 (58.65) | NA |
| • Overweight or obese | 46 (19.41) | 93 (39.24) | 98 (41.35) |
| • Repeat measurements of the obesity indicator | 163 (68.78) | 74 (31.22) | NA |
| • Medium-term outcomes for the obesity indicator* | 144 (60.76) | 93 (39.24) | NA |
| Alcohol consumption indicator | 58 (24.47) | 179 (75.53) | NA |
| • Elevated alcohol intake | 146 (61.60) | 33 (13.92) | 58 (24.47) |
| • Repeat measurements of the alcohol consumption indicator | 152 (64.14) | 85 (35.86) | NA |
| • Medium-term outcomes for the alcohol consumption indicator* | 212 (90.45) | 25 (10.55) | NA |
| Smoking status indicator† | 35 (14.77) | 202 (85.23) | NA |
| • Repeat measurements of the smoking status indicator | 119 (50.21) | 118 (49.79) | NA |
| Smoking cessation indicator‡ | 10 (25.64) | 29 (74.36) | NA |
| • Repeat measurements for the smoking cessation indicator‡ | 24 (61.54) | 15 (38.46) | NA |
| • Medium-term outcomes for the smoking cessation indicator*‡ | 9 (23.08) | 30 (76.92) | NA |
| T2DM indicator | 87 (36.71) | 150 (63.29) | NA |
| • Abnormal fasting plasma glucose | 139 (58.65) | 11 (4.64) | 87 (36.71) |
| • Repeat measurements for the T2DM indicator | 153 (64.56) | 84 (35.44) | NA |
| • Medium-term outcomes for the T2DM indicator* | 143 (60.34) | 94 (39.66) | NA |
| Cholesterol indicator | 41 (17.30) | 196 (82.70) | NA |
| • Abnormal serum cholesterol levels | 174 (73.42) | 22 (9.28) | 41 (17.30) |
| • Repeat measurements of the cholesterol indicator | 102 (43.04) | 135 (56.96) | NA |
| • Medium-term outcomes for the cholesterol indicator* | 138 (58.23) | 99 (41.77) | NA |
| BP indicator | 51 (21.52) | 186 (78.48) | NA |
| • Repeat measurements of the BP indicator | 91 (38.40) | 146 (61.60) | NA |
| • Medium-term outcomes for the BP indicator* | 141 (59.49) | 96 (40.51) | NA |
| Elevated BP at the 2003 annual physical examination | 184 (77.64) | 40 (16.88) | 13 (5.49) |
| • Follow-up of elevated BP indicator | 30 (75.00) | 10 (25.00) | NA |
| Global risk indicator | 175 (73.84) | 62 (26.16) | NA |
| • Elevated global risk assessment | 39 (16.46) | 23 (9.70) | 175 (73.84) |
| • Repeat measurements of the global risk indicator | 215 (90.72) | 22 (9.28) | NA |
BP—blood pressure, NA—not applicable, T2DM—type 2 diabetes mellitus.
↵* Positive behavioural change on the part of patients or physicians after indicator was initially collected.
↵† Of the 237 participants, 163 were non- or ex-smokers, 39 were current smokers, and 35 did not have the data available on their charts.
↵‡ Current smokers only.